XTL Biopharmaceutica Correlations
| XTLB Stock | USD 0.92 0.02 2.13% |
The current 90-days correlation between XTL Biopharmaceuticals and Avalo Therapeutics is 0.1 (i.e., Average diversification). The correlation of XTL Biopharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
XTL Biopharmaceutica Correlation With Market
Average diversification
The correlation between XTL Biopharmaceuticals Ltd and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding XTL Biopharmaceuticals Ltd and DJI in the same portfolio, assuming nothing else is changed.
Moving together with XTL Stock
Moving against XTL Stock
| 0.62 | 603122 | Cowealth Medical China | PairCorr |
| 0.4 | UPB | Upstream Bio, | PairCorr |
| 0.39 | ZBIO | Zenas BioPharma, Common | PairCorr |
| 0.32 | ERNA | Eterna Therapeutics | PairCorr |
| 0.31 | ZYME | Zymeworks Common Stock | PairCorr |
| 0.68 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.54 | 688670 | Jiangsu GDK Biotechnology | PairCorr |
| 0.53 | PYPD | PolyPid | PairCorr |
| 0.5 | CIZ | Cizzle Biotechnology | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between XTL Stock performing well and XTL Biopharmaceutica Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze XTL Biopharmaceutica's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| OABI | 2.90 | (0.46) | 0.00 | (0.13) | 0.00 | 6.21 | 17.86 | |||
| IVVD | 8.56 | 2.36 | 0.28 | 4.72 | 6.97 | 16.26 | 99.46 | |||
| SLS | 3.18 | (0.13) | 0.00 | (0.04) | 0.00 | 7.30 | 18.01 | |||
| CDXS | 3.17 | (1.06) | 0.00 | (0.29) | 0.00 | 5.91 | 25.89 | |||
| AVTX | 4.11 | 0.77 | 0.22 | 0.36 | 3.52 | 14.17 | 30.02 | |||
| PLX | 3.74 | 0.27 | 0.04 | 0.44 | 5.44 | 7.00 | 31.36 | |||
| CCCC | 4.29 | 0.16 | 0.04 | 0.16 | 4.80 | 9.90 | 51.62 | |||
| IMDX | 4.32 | 1.69 | 0.46 | 0.75 | 2.60 | 12.36 | 21.90 | |||
| SGMO | 3.54 | (0.33) | 0.00 | (0.11) | 0.00 | 7.41 | 28.86 | |||
| TARA | 3.60 | 0.84 | 0.27 | 0.59 | 2.76 | 13.97 | 26.91 |
XTL Biopharmaceutica Corporate Management
| Itay CPA | Chief Officer | Profile | |
| Itay Weinstein | Chief Officer | Profile | |
| Noam Band | Chief Officer | Profile | |
| Shlomo Shalev | CEO Director | Profile | |
| Ronen Kantor | Company Sec | Profile |